Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -4291.67% is 72% above its 5-year average of -15469.09%, near the high end of its 5-year range (-123703.30%–-958.36%).
74.67% above its 12-month average of -16943.09%.
Reported quarterly EBITDA margin; no daily interpolation. Q1 FY2026 (2026-03-31): -14386.44%.
EBITDA MARGIN
-4291.67%
EBITDA MARGIN AVG TTM
-16943.09%
EBITDA MARGIN AVG 3Y
-11973.28%
EBITDA MARGIN AVG 5Y
-15469.09%
EBITDA MARGIN AVG 10Y
-13312.05%
EBITDA MARGIN AVG 15Y
-11694.55%
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+74.67%
CURRENT VS 3Y AVG
+64.16%
CURRENT VS 5Y AVG
+72.26%
CURRENT VS 10Y AVG
+67.76%
CURRENT VS 15Y AVG
+63.30%
CURRENT VS 20Y AVG
N/A
BioRestorative Therapies, Inc.
Market Cap
$3.04M
EBITDA Margin
-4291.67%
TTM Avg
-16943.09%
3Y Avg
-11973.28%
5Y Avg
-15469.09%
Market Cap
$3.07M
EBITDA Margin
-22711.52%
TTM Avg
-15924.10%
3Y Avg
-12940.13%
5Y Avg
-12940.13%
Market Cap
$3.34M
EBITDA Margin
-2030.10%
TTM Avg
-2765.29%
3Y Avg
-1907.45%
5Y Avg
-2238.98%
Market Cap
$3.37M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.36M
EBITDA Margin
-437.97%
TTM Avg
-452.41%
3Y Avg
-479.95%
5Y Avg
-376.71%
Market Cap
$3.39M
EBITDA Margin
-334.54%
TTM Avg
-323.48%
3Y Avg
-700.81%
5Y Avg
-1335.84%
Market Cap
$2.62M
EBITDA Margin
-375.69%
TTM Avg
-244.00%
3Y Avg
-166.51%
5Y Avg
-121.60%
Market Cap
$2.75M
EBITDA Margin
-163.38%
TTM Avg
-126.27%
3Y Avg
-20964.27%
5Y Avg
-20964.27%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioRestorative Therapies, Inc. (BRTX) | $3.04M | -4291.67% | -16943.09% | -11973.28% | -15469.09% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.07M | -22711.52% | -15924.10% | -12940.13% | -12940.13% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.34M | -2030.10% | -2765.29% | -1907.45% | -2238.98% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.37M | N/A | N/A | N/A | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.36M | -437.97% | -452.41% | -479.95% | -376.71% |
| Evogene Ltd. (EVGN)vs › | $3.39M | -334.54% | -323.48% | -700.81% | -1335.84% |
| iSpecimen Inc. (ISPC)vs › | $2.62M | -375.69% | -244.00% | -166.51% | -121.60% |
| Eocene Ltd. (EOCN)vs › | $3.59M | N/A | N/A | N/A | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.75M | -163.38% | -126.27% | -20964.27% | -20964.27% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.52M | N/A | N/A | N/A | N/A |
Gross Margin
92.1%
EBITDA Margin
-4291.7%
Operating Margin
-4350.1%
Net Margin
-3089.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | -14386.44% |
| 2025-12-31 | -19247.27% |
| 2025-09-30 | -30986.36% |
| 2025-06-30 | -1072.38% |
| 2025-03-31 | -19023.01% |
| 2024-12-31 | -6096.47% |
| 2024-09-30 | -958.36% |
| 2024-06-30 | -2717.29% |
| 2024-03-31 | -11618.68% |
| 2023-12-31 | -16466.15% |
| 2023-09-30 | -9974.91% |
| 2023-06-30 | -4767.48% |
| 2023-03-31 | -18337.85% |
| 2022-12-31 | -123703.30% |
| 2022-09-30 | -15687.81% |
| 2022-06-30 | -6465.70% |
| 2022-03-31 | -31242.32% |
| 2021-12-31 | -79174.14% |
| 2021-09-30 | -45838.88% |
| 2021-06-30 | -23556.19% |
| 2021-03-31 | -83502.53% |
| 2020-12-31 | -4876.46% |
| 2020-09-30 | -3898.65% |
| 2020-06-30 | -2288.96% |
| 2020-03-31 | -2981.63% |
| 2019-12-31 | -6562.27% |
| 2019-09-30 | -4640.07% |
| 2019-06-30 | -6696.19% |
| 2019-03-31 | -7847.15% |
| 2018-12-31 | -7312.44% |
| 2018-09-30 | -4335.48% |
| 2018-06-30 | -5376.47% |
| 2018-03-31 | -11421.86% |
| 2017-12-31 | -3968.93% |
| 2017-09-30 | -10487.07% |
| 2017-06-30 | -12519.11% |
| 2017-03-31 | -34643.97% |
| 2016-12-31 | -29729.38% |
| 2016-09-30 | -32993.48% |
| 2016-06-30 | -12865.09% |
| 2016-03-31 | -21969.78% |
| 2015-12-31 | -1370.25% |
| 2015-09-30 | -1486.36% |
| 2015-06-30 | -815.36% |
| 2015-03-31 | -857.94% |
| 2014-12-31 | -1622.32% |
| 2014-09-30 | -545.40% |
| 2014-06-30 | -714.37% |
| 2014-03-31 | -374106.93% |
| 2013-09-30 | -882434.40% |
| 2013-06-30 | -255884.24% |
| 2013-03-31 | -112641.24% |
| 2012-12-31 | -445933.24% |
| 2012-09-30 | -22548.80% |
| 2012-06-30 | -13824.95% |
